UFP Technologies, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
UFP Technologies, Inc. (UFPT) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $31.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-02-27
- UFP Technologies, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was $31.00K, a 85.45% decline from fiscal 2024.
- UFP Technologies, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $213.00K, a 1320.00% increase from fiscal 2023.
- UFP Technologies, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $15.00K, a 94.88% decline from fiscal 2022.
- UFP Technologies, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $293.00K, a 63.69% increase from fiscal 2021.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $31.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $213.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $15.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $293.00K 10-K · filed 2025-03-03 | |
| 2021-12-31 | $179.00K 10-K · filed 2024-02-29 | |
| 2020-12-31 | $13.00K 10-K · filed 2023-03-16 | |
| 2019-12-31 | -$52.00K 10-K · filed 2022-03-14 | |
| 2018-12-31 | -$50.00K 10-K · filed 2021-03-12 | |
| 2017-12-31 | $116.00K 10-K · filed 2020-03-13 | |
| 2016-12-31 | $126.00K 10-K · filed 2019-03-15 | |
| 2015-12-31 | $16.00K 10-K · filed 2018-03-16 | |
| 2014-12-31 | $63.00K 10-K · filed 2017-03-10 | |
| 2013-12-31 | $22.00K 10-K · filed 2016-03-11 | |
| 2012-12-31 | $113.00K 10-K · filed 2015-03-13 | $112.92K 10-K · filed 2013-03-15 |
| 2011-12-31 | $55.00K 10-K · filed 2014-03-14 | $55.21K 10-K · filed 2013-03-15 |
| 2010-12-31 | $8.47K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |